touchpodcast
touchPODCAST
Welcome to touchPODCAST where you can listen and learn from our expert faculty, hand-picked from the Touch Medical Media family of independent medical websites. Educating physicians on a fully global scale since 2005!We make positive changes to clinical practice, with the ultimate objective of improving patient and community health. Working alongside leading medical experts, societies and industry, our mission is to provide practical, expert opinions to support best practices for busy Healthcare Professionals globally, by translating published data into easily digestible and timely updatesHome...
No dejes de visitar la web del podcast y apoyar a su creador: touchpodcast.podbean.com
Autor
touchpodcast
Categoría
Web del podcast
Último episodio
16 de oct. de 2026
¿Dónde escuchar?
Podcasts en la app Replaio Radio Muy prontoLos podcasts llegarán muy pronto a la app. Instálala ahora y sé el primero en descubrir una forma totalmente nueva de vivir los podcasts
Episodios
MDT perspectives on guidelines for stroke prevention in T2D 17.11.2022 10:49
touchMDT for touchENDOCRINOLOGY Listen to key experts from a multidisciplinary team discuss the current treatment guidelines for stroke management and prevention in patients with T2D and the key data that support them The multidisciplinary team Consultant neurologist: Prof. Georgios Tsivgoulis, Athens, Greece Consultant endocrinologist: Prof. Tina Vilsbøll, Copenhagen, Denmark This touchPODCAST is...
MDT perspectives on guidelines for stroke prevention in T2D 17.11.2022 10:47
touchMDT for touchNEUROLOGY Listen to key experts from a multidisciplinary team discuss the current treatment guidelines for stroke management and prevention in patients with T2D and the key data that support them The multidisciplinary team Consultant neurologist: Prof. Georgios Tsivgoulis, Athens, Greece Consultant endocrinologist: Prof. Tina Vilsbøll, Copenhagen, Denmark This touchPODCAST is for...
MDT and patient perspectives on the MDT’s role in stroke management 17.11.2022 12:28
touchMDT for touchENDOCRINOLOGY Listen to key experts from a multidisciplinary team, plus a patient with T2D who has survived a stroke, discuss how the MDT can effectively collaborate to improve stroke outcomes in patients with T2D in clinical practice The multidisciplinary team Consultant endocrinologist: Prof. Tina Vilsbøll, Copenhagen, Denmark Consultant neurologist: Prof. Georgios Tsivgoulis,...
MDT and patient perspectives on the MDT’s role in stroke management 17.11.2022 12:25
touchMDT for touchNEUROLOGY Listen to key experts from a multidisciplinary team, plus a patient with T2D who has survived a stroke, discuss how the MDT can effectively collaborate to improve stroke outcomes in patients with T2D in clinical practice The multidisciplinary team Consultant endocrinologist: Prof. Tina Vilsbøll, Copenhagen, Denmark Consultant neurologist: Prof. Georgios Tsivgoulis, Athe...
MDT perspectives on how GLP-1 RAs can reduce stroke risk 17.11.2022 14:44
touchMDT for touchNEUROLOGY Listen to key experts from a multidisciplinary team discuss how GLP-1 RAs can help to reduce the incidence of stroke in patients with T2D The multidisciplinary team Primary care physician: Dr Yassir Javaid, Northamptonshire, UK Consultant endocrinologist: Prof. Tina Vilsbøll, Copenhagen, Denmark Consultant neurologist: Prof. Georgios Tsivgoulis, Athens, Greece This touc...
MDT perspectives on how GLP-1 RAs can reduce stroke risk 17.11.2022 14:46
touchMDT for touchENDOCRINOLOGY Listen to key experts from a multidisciplinary team discuss how GLP-1 RAs can help to reduce the incidence of stroke in patients with T2D The multidisciplinary team Primary care physician: Dr Yassir Javaid, Northamptonshire, UK Consultant endocrinologist: Prof. Tina Vilsbøll, Copenhagen, Denmark Consultant neurologist: Prof. Georgios Tsivgoulis, Athens, Greece This...
Immunogenicity of immune checkpoint inhibitors: Implications for clinical practice 15.11.2022 35:46
touchPANEL DISCUSSION for touchONCOLOGY Listen to a panel of leading experts discuss the clinical relevance of the immunogenicity of immune checkpoint inhibitors for the treatment of cancer, informed by experience in inflammatory diseases. The experts: Prof. Peter Galle, University of Mainz, Germany, Dr Victor Moreno, START Madrid-FJD, Hospital Fundación Jiménez Díaz, Madrid, Spain, Dr Vibeke Stra...
MDT and patient perspectives on recognizing and referring patients with PNH 14.11.2022 12:57
touchMDT for touchONCOLOGY Listen to key experts from a multidisciplinary team, and a patient with PNH, discuss the signs and symptoms of PNH and how these inform the clinical diagnosis. The multidisciplinary team Primary care physician: Dr Will Evans, UK Haematologist: Professor Régis Peffault de Latour, France Patient: Ms Jess Ratcliffe, UK This touchPODCAST is for HCPs only. This activity is fu...
MDT perspectives on managing patients with complement inhibitors 14.11.2022 13:47
touchMDT for touchONCOLOGY Listen to key experts from a multidisciplinary team explore the use of complement inhibitors for patients with PNH. The multidisciplinary team Primary care physician: Dr Will Evans, UK Haematologist: Professor Régis Peffault de Latour, France This touchPODCAST is for HCPs only. This activity is funded by an independent medical education grant from Novartis. This medical...
MDT and patient perspectives on the patient journey in PNH 14.11.2022 13:50
touchMDT for touchONCOLOGY Listen to a haematologist and a patient with PNH discuss the experience of living with PNH from a patient’s perspective. The multidisciplinary team Haematologist: Professor Régis Peffault de Latour, France Patient: Ms. Jess Ratcliffe, UK This touchPODCAST is for HCPs only. This activity is funded by an independent medical education grant from Novartis. This medical educ...
Selecting the optimal treatment for patients with chronic myeloid leukaemia after two prior lines of therapy 03.11.2022 29:44
touchIN CONVERSATION for touchONCOLOGY Listen to two chronic myeloid leukaemia experts, Prof. Simona Soverini and Dr Daniela Žáčková discuss the mechanisms of action and latest data for new and emerging treatment options for patients with chronic myeloid leukaemia after two prior lines of therapy, and how they might impact the management of chronic myeloid leukaemia. The discussion is guided by p...
MDT perspectives on the pathophysiology and comorbidities of non-CF bronchiectasis touchRESPIRATORY 25.10.2022 11:33
Listen to key experts from a multidisciplinary team discuss the pathophysiology and comorbidities of non-CF bronchiectasis. The multidisciplinary team Primary care physician: Professor Barbara Yawn, USA Pulmonologist: Professor James Chalmers, Scotland This touchPODCAST is for HCPs only. This activity is funded by an independent medical education grant from Insmed. This medical education is jointl...
MDT and patient perspectives on the clinical presentation of non-CF bronchiectasis touchRESPIRATORY 25.10.2022 14:11
Listen to key experts from a multidisciplinary team, and a patient, explore the key signs and symptoms of non-CF bronchiectasis and how these inform the clinical diagnosis. The multidisciplinary team Pulmonologist: Professor James Chalmers, Scotland Primary care physician: Professor Barbara Yawn, USA Patient: Marta Almagro, Spain This touchPODCAST is for HCPs only. This activity is funded by an i...
MDT and patient perspectives on the diagnostic tools for non-CF bronchiectasis 25.10.2022 13:49
touchMDT for touchRESPIRATORY Listen to key experts from a multidisciplinary team, and a patient, review the diagnostic tools for non-CF bronchiectasis. The multidisciplinary team Primary care physician: Professor Barbara Yawn, USA Pulmonologist: Professor James Chalmers, Scotland Radiologist: Professor Mary Salvatore, USA Patient: Marta Almagro, Spain This touchPODCAST is for HCPs only. This act...
MDT perspectives on the pathophysiology and comorbidities of non-CF bronchiectasis 25.10.2022 11:35
touchMDT for touchINFECTIOUS DISEASES Listen to key experts from a multidisciplinary team discuss the pathophysiology and comorbidities of non-CF bronchiectasis. The multidisciplinary team Primary care physician: Professor Barbara Yawn, USA Pulmonologist: Professor James Chalmers, Scotland This touchPODCAST is for HCPs only. This activity is funded by an independent medical education grant from In...
MDT and patient perspectives on the clinical presentation of non-CF bronchiectasis 25.10.2022 14:14
touchMDT for touchINFECTIOUS DISEASES Listen to key experts from a multidisciplinary team, and a patient, explore the key signs and symptoms of non-CF bronchiectasis and how these inform the clinical diagnosis. The multidisciplinary team Pulmonologist: Professor James Chalmers, Scotland Primary care physician: Professor Barbara Yawn, USA Patient: Marta Almagro, Spain This touchPODCAST is for HCPs...
MDT and patient perspectives on the diagnostic tools for non-CF bronchiectasis 25.10.2022 13:51
touchMDT for touchINFECTIOUS DISEASES Listen to key experts from a multidisciplinary team, and a patient, review the diagnostic tools for non-CF bronchiectasis. The multidisciplinary team Primary care physician: Professor Barbara Yawn, USA Pulmonologist: Professor James Chalmers, Scotland Radiologist: Professor Mary Salvatore, USA Patient: Marta Almagro, Spain This touchPODCAST is for HCPs only....
Experts discuss latest guidelines and how novel treatments can reduce ASCVD risk in patients with dyslipidemias 11.10.2022 30:53
touchIN CONVERSATION for touchCARDIO Listen to Prof. Kausik Ray in conversation with Dr Mahir Karakas. They respond to questions submitted by the HCP audience and provide their expert insights on how the latest guidelines and treatments can be applied to reduce ASCVD risk in patients with dyslipidemias. This touchPODCAST is for HCPs only. This activity is funded by an unrestricted independent m...
Experts in endocrinology and in primary care discuss addressing cardiorenal outcomes in CKD and T2D 11.10.2022 38:33
touch INCONVERSATION for touchENDOCRINOLOGY Listen to Prof. Peter Rossing in conversation with Dr Eden Miller. They respond to questions submitted by the HCP audience and provide their expert insights on monitoring CKD progression, reducing the risk of cardiorenal outcomes, and applying the latest guidelines on CKD and T2D to daily practice. This touchPODCAST is for HCPs only. his activity is fu...
Experts in endocrinology and in primary care discuss addressing cardiorenal outcomes in CKD and T2D 11.10.2022 38:32
touch IN CONVERSATION for touchCARDIOLOGY Listen to Prof. Peter Rossing in conversation with Dr Eden Miller. They respond to questions submitted by the HCP audience and provide their expert insights on monitoring CKD progression, reducing the risk of cardiorenal outcomes, and applying the latest guidelines on CKD and T2D to daily practice. This touchPODCAST is for HCPs only. This activity is fun...
Getting personal: Individualizing therapy for cold agglutinin disease 10.10.2022 26:27
touchEXPERT OPINIONS for touchONCOLOGY Listen to two leading experts give their insights on the recommended workup for a timely and accurate diagnosis, as well as the evolving treatment landscape, and importance of individualizing therapy for patients with cold agglutinin disease. The experts Dr Catherine M Broome, MedStar Georgetown University Hospital Washington DC, USA Dr Ilene Ceil Weitz, J...
Understanding the immunopathogenesis of CAD: What are the implications of new and emerging therapies? 05.10.2022 32:56
touchPANEL DISCUSSION for touchIMMUNOLOGY Listen to a panel of leading experts discuss the pathophysiology of cold agglutinin disease (CAD), the steps needed for an accurate diagnosis, and how emerging treatment options are changing the management of patients with primary CAD. The experts Prof. Morie Gertz, Mayo Clinic, Rochester, Minnesota, USA Prof. Bernd Jilma, Medical University of Vienna, Au...
Understanding the immunopathogenesis of CAD: What are the implications of new and emerging therapies? 05.10.2022 32:56
touchPANEL DISCUSSION for touchONCOLOGY Listen to a panel of leading experts discuss the pathophysiology of cold agglutinin disease (CAD), the steps needed for an accurate diagnosis, and how emerging treatment options are changing the management of patients with primary CAD. The experts Prof. Morie Gertz, Mayo Clinic, Rochester, Minnesota, USA, Prof. Bernd Jilma, Medical University of Vienna, Au...
Advances in immunotherapies and targeted treatments for patients with bladder cancer: An update from ESMO 2022 03.10.2022 58:44
touchCONGRESS for touchONCOLOGY Listen to urological cancer expert Prof. Axel Merseburger (Germany) review key data presented at ESMO 2022 exploring recent advances in immunotherapies and targeted treatments for patients with bladder cancer. He then offers his views on the potential impact of these data on clinical practice, alongside expert insights from Dr Bradley McGregor (USA) and Prof. Andre...
Managing MS in patients over their lifetime 29.09.2022 11:54
touchMDT for touchNEUROLOGY Listen to two neurologists specializing in MS care discuss the management of MS throughout the lifetime of patients and consider treatment switching strategies at key milestones (e.g. during the paediatric, childbearing and elderly years). The experts Neurologist/MS specialist: Prof. Tjalf Ziemssen, Germany Neurologist/MS specialist: Prof. Tobias Derfuss, Switzerland Th...
Podcasts similares
Replaio no es editor de podcasts; los nombres de los programas, las portadas y el audio pertenecen a sus autores y se distribuyen a través de canales RSS públicos